PF-06687859(RG3039) CAS:1005504-62-0
PF-06687859(RG3039)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1996 | 100mg | 425.00 | + Add to cart |
|
| R-C-1996 | 200mg | 790.00 | + Add to cart |
|
| R-C-1996 | 500mg | 1450.00 | + Add to cart |
|
|
|
||||
Product description
RG3039(PF-06687859)is a potent DcpS inhibitor.DcpS is a therapeutic target for spinal muscular atrophy.Spinal muscular atrophy(SMA)is caused by deletion or mutation of both copies of the SMN1 gene which produces an essential protein known as SMN.RG3039 improves motor function in SMA mice.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---PF-06687859(RG3039)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


